ConductScience.org, home

Library / Genes

CCL21: C-C motif chemokine ligand 21

1 protein, 261 patents, 0 drugs, 0 trials, 3,676 NIH grants and 6,067 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCCL21HGNC
NameC-C motif chemokine ligand 21HGNC
NCBI Gene ID6366NCBI Gene
HGNC IDHGNC:10620HGNC
EnsemblENSG00000137077NCBI Gene
Aliases6Ckine, CKb9, ECL, SCYA21, SLC, TCA4, exodus-2NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
O00585C-C motif chemokine 211345Ensembl, GeneID, HGNCUniProt

Patents 261

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026120675 A2026-07-22737O00585Espacenet
EP 4750797 A12026-06-0350O00585Espacenet
EP 4705273 A22026-03-11246O00585Espacenet
EP 4705273 A22026-03-11346O00585Espacenet
EP 4705273 A22026-03-11419O00585Espacenet
EP 4705273 A22026-03-11436O00585Espacenet
EP 4678241 A22026-01-1446O00585Espacenet
JP 2026004568 A2026-01-1441010O00585Espacenet
EP 4650780 A22025-11-191755O00585Espacenet
JP 2025163187 A2025-10-282O00585Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3676

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant222,025NIH's project files
P30CA044579University of Virginia Cancer Center Support Grant172,025NIH's project files
P30CA008748Cancer Center Support Grant132,025NIH's project files
P30CA047904Cancer Center Support Grant132,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award132,025NIH's project files
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital122,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant112,025NIH's project files
T32AI007496Interdisciplinary Training Program in Immunology112,025NIH's project files
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)82,025NIH's project files
P30CA016042Cancer Center Support Grant82,025NIH's project files

Papers 6067

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42779625PubTator, text miningPubMed
42749753PubTator, text miningPubMed
42622342PubTator, text miningPubMed
42617740PubTator, text miningPubMed
42588967PubTator, text miningPubMed
42578470PubTator, text miningPubMed
42550967PubTator, text miningPubMed
42550812PubTator, text miningPubMed
42523291PubTator, text miningPubMed
42498884PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license